205 related articles for article (PubMed ID: 21175904)
1. Haemolytic anaemia and renal failure associated with antibodies to trimethoprim and sulfamethoxazole.
Arndt PA; Garratty G; Wolf CF; Rivera M
Transfus Med; 2011 Jun; 21(3):194-8. PubMed ID: 21175904
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to co-trimoxazole (trimethoprim and/or sulfamethoxazole) related to the presence of the drug in a commercial low-ionic-strength solution.
Pham BN; Gien D; Bensaad F; Babinet J; Dubeaux I; Rouger P; Le Pennec PY
Transfusion; 2012 Apr; 52(4):844-8. PubMed ID: 21910740
[TBL] [Abstract][Full Text] [Related]
3. The first reported case of concurrent trimethoprim-sulfamethoxazole-induced immune hemolytic anemia and thrombocytopenia.
Linnik YA; Tsui EW; Martin IW; Szczepiorkowski ZM; Denomme GA; Gottschall JL; Hill JM; Dunbar NM
Transfusion; 2017 Dec; 57(12):2937-2941. PubMed ID: 28905389
[TBL] [Abstract][Full Text] [Related]
4. Possible Trimethoprim-Sulfamethoxazole-Induced Hemolytic Anemia: A Case Report.
Williams MF; Doss EP; Montgomery M
J Pharm Pract; 2017 Dec; 30(6):653-657. PubMed ID: 29121838
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Pneumocystis carinii pneumonia in patients with AIDS.
Wordell CJ; Hauptman SP
Clin Pharm; 1988 Jul; 7(7):514-27. PubMed ID: 3138063
[TBL] [Abstract][Full Text] [Related]
6. Possible trimethoprim/sulfamethoxazole-induced aseptic meningitis.
Therrien R
Ann Pharmacother; 2004 Nov; 38(11):1863-7. PubMed ID: 15367724
[TBL] [Abstract][Full Text] [Related]
7. Successful outpatient graded administration of trimethoprim-sulfamethoxazole in patients without HIV and with a history of sulfonamide adverse drug reaction.
Pyle RC; Butterfield JH; Volcheck GW; Podjasek JC; Rank MA; Li JT; Harish A; Poe KL; Park MA
J Allergy Clin Immunol Pract; 2014; 2(1):52-8. PubMed ID: 24565769
[TBL] [Abstract][Full Text] [Related]
8. Two cases of immune haemolytic anaemia, associated with anti-piperacillin, detected by the 'immune complex' method.
Arndt PA; Garratty G; Hill J; Kasper M; Chandrasekaran V
Vox Sang; 2002 Oct; 83(3):273-8. PubMed ID: 12366773
[TBL] [Abstract][Full Text] [Related]
9. Immune hemolytic anemia with drug-induced antibodies to carboplatin and vincristine in a pediatric patient with an optic pathway glioma.
Betensky M; Witmer C; Fisher MJ; Nance S; Weiss MJ; Sesok-Pizzini DA
Transfusion; 2014 Nov; 54(11):2901-5. PubMed ID: 24860959
[TBL] [Abstract][Full Text] [Related]
10. Blunted humoral response to influenza vaccination in patients exposed to zidovudine plus trimethoprim-sulfamethoxazole.
Feola DJ; Garvy BA; Rapp RP; Thornton AC
Pharmacotherapy; 2007 Jul; 27(7):937-47. PubMed ID: 17594199
[TBL] [Abstract][Full Text] [Related]
11. Hyponatremia after initiation and rechallenge with trimethoprim-sulfamethoxazole in an older adult.
Huntsberry AM; Linnebur SA; Vejar M
Clin Interv Aging; 2015; 10():1091-6. PubMed ID: 26170649
[TBL] [Abstract][Full Text] [Related]
12. Aetiological factors related to a positive direct antiglobulin test result in human immunodeficiency virus-infected patients.
Lai M; d'Onofrio G; Visconti E; Tamburrini E; Cauda R; Leone G
Vox Sang; 2006 May; 90(4):325-30. PubMed ID: 16635076
[TBL] [Abstract][Full Text] [Related]
13. Drug-induced aseptic meningitis secondary to trimethoprim/sulfamethoxazole: a headache to be aware of.
Lockwood JR; Carr D
CJEM; 2014 Sep; 16(5):421-4. PubMed ID: 25227653
[TBL] [Abstract][Full Text] [Related]
14. Metabolite-specific (IgG) and drug-specific antibodies (IgG, IgM) in two cases of trimethoprim-sulfamethoxazole-induced immune thrombocytopenia.
Kiefel V; Santoso S; Schmidt S; Salama A; Mueller-Eckhardt C
Transfusion; 1987; 27(3):262-5. PubMed ID: 3296342
[TBL] [Abstract][Full Text] [Related]
15. Trimethoprim-sulfamethoxazole (TMP/SMX) potentiates indinavir nephrotoxicity.
de Araujo M; Seguro AC
Antivir Ther; 2002 Sep; 7(3):181-4. PubMed ID: 12487385
[TBL] [Abstract][Full Text] [Related]
16. Trimethoprim-induced immune hemolytic anemia in a pediatric oncology patient presenting as an acute hemolytic transfusion reaction.
Gupta S; Piefer CL; Fueger JT; Johnson ST; Punzalan RC
Pediatr Blood Cancer; 2010 Dec; 55(6):1201-3. PubMed ID: 20589632
[TBL] [Abstract][Full Text] [Related]
17. Severe thrombocytopenia possibly associated with TMP/SMX therapy.
Yamreudeewong W; Fosnocht BJ; Weixelman JM
Ann Pharmacother; 2002 Jan; 36(1):78-82. PubMed ID: 11816265
[TBL] [Abstract][Full Text] [Related]
18. Symptomatic hypoglycemia associated with trimethoprim/sulfamethoxazole and repaglinide in a diabetic patient.
Roustit M; Blondel E; Villier C; Fonrose X; Mallaret MP
Ann Pharmacother; 2010 Apr; 44(4):764-7. PubMed ID: 20197475
[TBL] [Abstract][Full Text] [Related]
19. Apparent hemolysis in an AIDS patient receiving trimethoprim/sulfamethoxazole: case report and literature review.
Reinke CM; Thomas JK; Graves AH
J Pharm Technol; 1995; 11(6):256-62; quiz 293-5. PubMed ID: 10157546
[TBL] [Abstract][Full Text] [Related]
20. Trimethoprim-associated hyponatremia.
Babayev R; Terner S; Chandra S; Radhakrishnan J; Mohan S
Am J Kidney Dis; 2013 Dec; 62(6):1188-92. PubMed ID: 23891358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
